Prostate Cancer UK's Board of Trustees has appointed the next
Chair of its rapidly expanding organisation. William Russell will
take on the role in October at an exciting time for the charity as
it builds up the momentum in its fight to transform the landscape
of men's health.
William Russell, who spent the majority of his career at
American investment bank Merrill Lynch, has been a Trustee of Prostate
Cancer UK for five years, alongside other entrepreneurial
commitments and his role as an Alderman of the City of London
Corporation. He will formally take over his new role from
current Chair, Professor Paul Forster, on 18 October 2013.
Forster, who has held the position of Chair since 2005, is
stepping down following a successful period in which the Charity
has grown dramatically. He extended his period of office for an
additional year in order to oversee the merger between The Prostate
Cancer Charity and Prostate Action to form Prostate Cancer UK.
Of the new venture Russell said: "I applied for the role of
Trustee five years ago after becoming increasingly aware of the
problems and manifold challenges that surround prostate cancer.
When you look at the success of the breast cancer charities and the
progress they have made, it's obvious that men had (and still have)
a lot of ground to make up. I've very much enjoyed my time here so
far, and am now very much looking forward to taking on the new
challenge as Chair of the Board.
"Paul has done an outstanding job in this role, and the charity
is now in a position to develop large scale plans in terms of
service provision, investment in research and awareness raising. It
is now my commitment to build on this, deliver against those plans
and ensure that we propel the organisation onward and upward to
bring about real change for men."
Prostate cancer is the most common cancer in men and set to be
the most common cancer overall by 2030. Prostate Cancer UK's
mission is to bring about significant change in the field of
prostate cancer and prostate disease to ensure that more men
survive and have a better quality of life in the future.
Owen Sharp, Chief Executive of prostate Cancer UK said: "I am
delighted that William has agreed to take on the challenge of Chair
of the Board. Under the steadfast leadership of Paul, our current
Chair, the charity has developed rapidly in recent years from an
organisation in its infancy to what is now the largest men's health
charity in the UK. We now have the foundations firmly in place to
drive us forward in to the next phase and increase our impact yet
further. I have total confidence that with his business background
and in depth understanding of the cause, William is the best man to
oversee our development during this next chapter. I look forward to
working closely with him and the rest of the team to build a better
future for men."
Paul Forster, who has himself been treated for prostate cancer
said of his time at the charity: "When I became Chair of what was
then the Prostate Cancer Charity, we employed less than 20 people
in one small office. I am proud to have had the opportunity to
oversee its transformation in to what is now a thriving
organisation of over 170 people with offices all across the UK, but
which retains its innovative and entrepreneurial culture dedicated
to helping more men survive prostate cancer. We are now on a
much greater platform to reach men and this is the perfect time for
William to pick up the reins and steer this excellent organisation
to reach even greater heights."